Javier Szwarcberg

Chief Executive Officer at SPRUCE BIOSCIENCES, INC.

Net worth: 974 335 $ as of 31/05/2026

56 year

Health Technology

Consumer Services

Profile

Javier Szwarcberg is Chief Executive Officer & Executive Director at Spruce Biosciences, Inc. since 2022.
Formerly, Dr. Szwarcberg was Group VP, Head-Product & Portfolio Development at BioMarin Pharmaceutical, Inc. from 2020 to 2022, Senior VP-Program & Portfolio Management at Ultragenyx Pharmaceutical, Inc. from 2017 to 2020, and Vice President-Clinical & Business Development at Horizon Therapeutics Ltd. (Ireland) from 2016 to 2017.
Education includes a doctorate from Universidad de Buenos Aires and graduate studies at Harvard T.H.
Chan School of Public Health.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SPRUCE BIOSCIENCES, INC. 1.78%	24/03/2026	19,004 ( 1.78% )	974 335 $	31/05/2026

Javier Szwarcberg active positions

Companies	Position	Start
SPRUCE BIOSCIENCES, INC.	Chief Executive Officer	03/01/2022

All active positions of Javier Szwarcberg

Former positions of Javier Szwarcberg

Companies	Position	End
BIOMARIN PHARMACEUTICAL INC.	Corporate Officer/Principal	01/01/2022
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	01/02/2020
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY	Chief Tech/Sci/R&D Officer	01/10/2017

See the detail of Javier Szwarcberg's experience

Training of Javier Szwarcberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Javier Szwarcberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
BioMarin Pharmaceutical, Inc. BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions	Health Technology
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Horizon Therapeutics Ltd. (Ireland) Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals	Health Technology
Universidad de Buenos Aires Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard T.H. Chan School of Public Health Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spruce Biosciences, Inc. Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases	Health Technology